Susie N. Hong-Zohlman, MD, MSc

• Bachelor of Arts, University of Pennsylvania, Philadelphia, PA
• Medical Degree, Thomas Jefferson University, Philadelphia, PA
• Residency, Internal Medicine, Mount Sinai Hospital, New York, NY
• Fellowship, General Cardiology, New York University Langone Medical Center, New York, NY
• Advanced Imaging Fellowship, Cardiovascular Magnetic Resonance Imaging and Research, Beth Israel Deaconess Medical Center, Boston, MA
• Master of Science, Epidemiology, Harvard School of Public Health, Boston, MA

Dr. Hong-Zohlman is the Medical Director of the Echocardiography Laboratory at the University of Maryland Medical Center.  Her major research interests are in advanced noninvasive cardiovascular imaging and the use of multimodality imaging to identify sex differences in cardiovascular disease, particularly in infiltrative cardiomyopathies such as hypertrophic cardiomyopathy, and diseases involving the pericardium.  With her secondary appointment in Diagnostic Radiology and Nuclear Medicine, Dr. Hong-Zohlman works closely with Drs. Jean Jeudy and Charles White in Thoracic Radiology with regard to cardiovascular magnetic resonance imaging and cardiac computed tomography, both within research and in clinical care.

Dr. Hong-Zohlman is trained in all cardiovascular noninvasive imaging modalities, including echocardiography (Level 3), cardiovascular magnetic resonance imaging (Level 3), nuclear cardiology (Level 2), and computed cardiac tomography (Level 2). She is also board certified in cardiovascular medicine, echocardiography, and nuclear medicine.

Cardiovascular Imaging (cardiovascular magnetic resonance imaging, echocardiography, cardiac computed tomography, nuclear cardiology) Pericardial Disease Myocarditis Hypertrophic Cardiomyopathy Cardiovascular Disease in Women

Khan AN, Desai K, Zviman A, Hong SN, Ananthram M, Liu S, Srivastava MC, Benitez M, Hong CC, Dickfeld TM, Restrepo AJ.  Balancing Service and Safety: Cardiovascular Medicine Divisional Response to the COVID-19 Pandemic. JACC Case Reports 2020 Jul;2(9):1368-1375.  doi.org/10.1016/j.jaccas.2020.05.058

Whalen H, Dako F, Patel P, Sahbaz J, Hong-Zohlman S, White CS, Jeudy J.  Role of Imaging for Suspected Cardiac Thrombus.  Curr Treat Options Cardiovasc Med. 2019 Dec 9;21(12):81. doi: 10.1007/s11936-019-0792-6.

Chen H, Watnick T, Hong SN, Daly B, Li Y, Seliger SL.  Left ventricular hypertrophy in a contemporary cohort of autosomal dominant polycystic kidney disease patients. BMC Nephrol. 2019 Oct 25;20(1):386. doi: 10.1186/s12882-019-1555-z.

Lassen MCH, Qasim AN, Biering-Sørensen T, Reeh JLT, Watnick T, Seliger SL, Chen H, Sawan MA, Nguyen D, Li Y, Hong SN, Park M.  Cardiac function assessed by myocardial deformation in adult polycystic kidney disease patients.  BMC Nephrol. 2019 Aug 16;20(1):324. doi: 10.1186/s12882-019-1500-1.

Peters MN, Seliger SL, Christenson RH, Hong-Zohlman SN, Daniels LB, Lima JAC, de Lemos JA, Neeland IJ, deFilippi CR.  "Malignant" Left Ventricular Hypertrophy Identifies Subjects at High Risk for Progression to Asymptomatic Left Ventricular Dysfunction, Heart Failure, and Death: MESA (Multi-Ethnic Study of Atherosclerosis).  J Am Heart Assoc. 2018 Feb 8;7(4):e006619. doi: 10.1161/JAHA.117.006619.

Hong SN, Seliger SL, Christenson RH, Kronmal R, Daniels LB, Lima JA, de Lemos JA, Bertoni AG, deFilippi CR. High Sensitive Cardiac Troponin T as an Early Biochemical Signature for Clinical and Subclinical Heart Failure: The Multi-Ethnic Study of Atherosclerosis.  Circulation. 2017 Feb 3. pii: CIRCULATIONAHA.116.025505. doi: 10.1161/CIRCULATIONAHA.116.025505. [Epub ahead of print]. PMID: 28159799

Terpenning S, Deng M, Hong-Zohlman SN, Lin CT, Kligerman SJ, Jeudy J, Ketai LH. CT measurement of central pulmonary arteries to diagnose pulmonary hypertension (PHTN): more reliable than valid? Clin Imaging. 2016 Jul-Aug;40(4):821-7. doi: 10.1016/j.clinimag.2016.02.024. PMID: 27131412

Li C, Lin CT, Kligerman SJ, Hong SN, White CS. Enhancement Characteristics of the Computed Tomography Pulmonary Angiography Test Bolus Curve and Its Use in Predicting Right Ventricular Dysfunction and Mortality in Patients With Acute Pulmonary Embolism. J Thorac Imaging. 2015 Jul;30(4):274-81. doi: 10.1097/RTI.0000000000000141. PMID: 25635705

Chan RH, Maron BJ, Olivotto I, Pencina MJ, Assenza GE, Haas T, Lesser JR, Gruner C, Crean AM, Rakowski H, Udelson JE, Rowin E, Lombardi M, Cecchi F, Tomberli B, Spirito P, Formisano F, Biagini E, Rapezzi C, De Cecco CN, Autore C, Cook EF, Hong SN, Gibson CM, Manning WJ, Appelbaum E, Maron MS. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.  Circulation. 2014 Aug 5;130(6):484-95. doi: 10.1161/CIRCULATIONAHA.113.007094. PMID: 25092278

Hong SN, Gona P, Fontes JD, Oyama N, Chan RH, Kenchaiah S, Tsao CW, Yeon SB, Schnabel RB, Keaney JF, O'Donnell CJ, Benjamin EJ, Manning WJ.  Atherosclerotic biomarkers and aortic atherosclerosis by cardiovascular magnetic resonance imaging in the Framingham Heart Study.  J Am Heart Assoc. 2013 Nov 15;2(6):e000307. doi: 10.1161/JAHA.113.000307. PMID: 24242683

Nam S, Hong SN, Akçakaya M, Kwak Y, Goddu B, Kissinger KV, Manning WJ, Tarokh V, Nezafat R.  Atherosclerotic biomarkers and aortic atherosclerosis by cardiovascular magnetic resonance imaging in the Framingham Heart Study. J Magn Reson Imaging. 2014 Jan;39(1):179-88. doi: 10.1002/jmri.24098. PMID: 23857797